v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenues        
Total revenues $ 546,600 $ 413,351 $ 1,048,431 $ 781,092
Cost and expenses        
Research and development 146,427 89,109 275,504 177,746
Selling, general and administrative 310,549 197,965 577,414 392,243
Total cost and expenses 656,972 457,253 1,237,978 899,308
Loss from operations (110,372) (43,902) (189,547) (118,216)
Interest expense (1,029) (3,127) (2,034) (6,251)
Interest and other income, net 10,738 10,457 24,155 20,724
Loss before income taxes (100,663) (36,572) (167,426) (103,743)
Income tax expense (275) (892) (448) (1,320)
Net loss (100,938) (37,464) (167,874) (105,063)
Unrealized (loss) gain on available-for-sale securities, net of tax (90) 834 57 1,727
Comprehensive loss $ (101,028) $ (36,630) $ (167,817) $ (103,336)
Net loss per share (Note 12):        
Basic (in dollars per share) $ (0.74) $ (0.3) $ (1.24) $ (0.86)
Diluted (in dollars per share) $ (0.74) $ (0.30) $ (1.24) $ (0.86)
Weighted-average number of shares used in computing basic and diluted net loss per share:        
Basic (in shares) 136,388 122,853 135,632 121,834
Diluted (in shares) 136,388 122,853 135,632 121,834
Product        
Revenues        
Total revenues $ 544,427 $ 411,364 $ 1,044,463 $ 776,036
Cost and expenses        
Cost of revenues 199,531 169,850 384,143 328,683
Licensing and other        
Revenues        
Total revenues 2,173 1,987 3,968 5,056
Cost and expenses        
Cost of revenues $ 465 $ 329 $ 917 $ 636